Next-Generation Sequencing Panel Test in Myeloid Neoplasms and Evaluation with the Clinical Results

Yüce Kahraman, Çiğdem; Sincan, Gülden; Tatar, Abdulgani

doi:10.5152/eurasianjmed.2022.21102

Makale Tam Makale Uluslararası 2022

Next-Generation Sequencing Panel Test in Myeloid Neoplasms and Evaluation with the Clinical Results

Çiğdem Yüce Kahraman, Gülden Sincan, Abdulgani Tatar

EURASIAN JOURNAL OF MEDICINE Cilt 54 · Sayı 2 · ss. 181–185 · 01.06.2022

DOI ile aç

Özet

Objective: Myeloid malignancies are heterogeneous disorders due to defective hematopoiesis and myeloid differentiation of hematopoietic stem/progenitor cell. The molecular landscape of the diseases is complex. Molecular alterations are used for classification and evaluation of prognosis and treatment. We aimed to evaluate the advantages of the next-generation sequencing panel testing in myeloid malignancies and clinical outcomes.

Anahtar kelimeler

DIAGNOSIS MUTATION BIOLOGY AML POLYCYTHEMIA-VERA Myeloid malignancies NGS panel testing myeloid panel testing

Atıf için künye

Yüce Kahraman, Ç., Sincan, G., & Tatar, A. (2022). Next-Generation Sequencing Panel Test in Myeloid Neoplasms and Evaluation with the Clinical Results. EURASIAN JOURNAL OF MEDICINE, 54(2), 181–185. https://doi.org/10.5152/eurasianjmed.2022.21102

BibTeX

@article{yucekahraman2022-227825,
  author = {Yüce Kahraman, Çiğdem and Sincan, Gülden and Tatar, Abdulgani},
  title = {Next-Generation Sequencing Panel Test in Myeloid Neoplasms and Evaluation with the Clinical Results},
  journal = {EURASIAN JOURNAL OF MEDICINE},
  year = {2022},
  volume = {54},
  number = {2},
  pages = {181--185},
  issn = {1308-8734},
  doi = {10.5152/eurasianjmed.2022.21102},
  url = {https://akademik.atauni.edu.tr/yayinlar/227825-next-generation-sequencing-panel-test-in-myeloid-neoplasms-and-evaluation-with}
}